Liquidia LQDA
NASDAQ LQDA
$71.08 -4.25 (-5.64%)
As of: Aug 20, 2026 · 3:59 PM EDT

Liquidia (LQDA) Short term Debt (2019)

Liquidia (LQDA) posted quarterly Short term Debt of $5.6 million for Q4 2019.

Liquidia (LQDA) Short term Debt (2019) Analysis & Trends

Liquidia's Short term Debt history runs 1 years deep, the most recent figure standing at $5.6 million for Q4 2019.

  • In Q4 2019, Short term Debt changed N/A year-over-year to $5.6 million; the TTM figure through Dec 2019 stood at $5.6 million (changed N/A YoY), while the FY2019 annual figure was $5.6 million, changed N/A from the prior year.
  • Short term Debt for Q4 2019 stood at $5.6 million.
  • The five-year high for Short term Debt was $5.6 million in Q4 2019, with the low at $5.6 million in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Liquidia 6.31 Bn 6.03 Bn 160.92 Mn

Historic Data

Download Data
DateValue
Dec 31, 2019 5.59 Mn